Combination nivolumab and ipilimumab or nivolumab alone in melanoma brain metastases: a multicentre randomised phase 2 study

Long, GV; Atkinson, V; Lo, S; Sandhu, S; Guminski, AD; Brown, MP; Wilmott, JS; Edwards, J; Gonzalez, M; Scolyer, RA; Menzies, AM; McArthur, GA

Long, GV (reprint author), Univ Sydney, Melanoma Inst Australia, Sydney, NSW 2065, Australia.

LANCET ONCOLOGY, 2018; 19 (5): 672

Abstract

Background Nivolumab monotherapy and combination nivolumab plus ipilimumab increase proportions of patients achieving a response and survival versus i......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索